Trial intelligence / Profile preview

Comparison of insulin Detemir vs insulin Glargine on weight gain in young women with type 1 diabetes

2007-004144-74Phase 4Terminated

Sponsor
Cambridge University Hospitals NHS Foundation Trust
Start
Oct 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of insulin detemir and insulin glargine in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: BMI standard deviation score after 1 year. Started Oct 2007; status: terminated.

02

Drugs

insulin detemirinsulin glargine
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2007-004144-74.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004144-74.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call